Spybiotech

Spybiotech company information, Employees & Contact Information

Explore related pages

Related company profiles:

SpyBiotech is a UK-based company with a novel vaccine platform to target infectious diseases, cancer and chronic diseases. SpyBiotech was spun out of the University of Oxford in 2017. Its proprietary protein superglue technology binds antigens to vaccine delivery platforms in a way which minimizes delivery risk and enhances immunogenicity and efficacy. The company’s current lead candidate is against human cytomegalovirus (HCMV), with clinical studies planned for this year.

Company Details

Employees
25
Founded
-
Address
7600 Quorum,
Phone
4401865582088
Email
co****@****ech.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
HQ
Oxford
Looking for a particular Spybiotech employee's phone or email?

Spybiotech Questions

News

SpyBiotech Fortifies Board with Biotech Veteran Stuart Chaffee - Business Wire

SpyBiotech Fortifies Board with Biotech Veteran Stuart Chaffee Business Wire

SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer - citybiz

SpyBiotech Appoints Dr. Prakash Bhuyan as Chief Medical Officer citybiz

Prakash Bhuyan named SpyBiotech CMO - The Pharma Letter

Prakash Bhuyan named SpyBiotech CMO The Pharma Letter

Spybiotech, University of Oxford collaborate on vaccine against Epstein-Barr virus - BioWorld MedTech

Spybiotech, University of Oxford collaborate on vaccine against Epstein-Barr virus BioWorld MedTech

Mega fundraiser boosts SpyBiotech board - Business Weekly

Mega fundraiser boosts SpyBiotech board Business Weekly

SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLP01 Targeting Human Cytomegalovirus (HCMV) - Business Wire

SpyBiotech Announces the Completion of Enrollment in Phase I Trial of SPYVLP01 Targeting Human Cytomegalovirus (HCMV) Business Wire

Oxford’s SpyBiotech secures £23.5M to accelerate its COVID-19 vaccine technology platform - UKTN

Oxford’s SpyBiotech secures £23.5M to accelerate its COVID-19 vaccine technology platform UKTN

Biochemical superglue opens new approach to vaccine development - University of Oxford

Biochemical superglue opens new approach to vaccine development University of Oxford

Meet Prof Sumi Biswas, co-founder of SpyBiotech, that helps COVID vaccine rapid generation - Get Bengal

Meet Prof Sumi Biswas, co-founder of SpyBiotech, that helps COVID vaccine rapid generation Get Bengal

Top Spybiotech Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant